Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Severe diarrhea on a weekly diabetes/weight-loss shot — considering stopping

Someone on an online forum said they started semaglutide injections (the weekly dose used for weight loss and diabetes) and, after increasing from 0.25 mg to 0.5 mg and then 1 mg, began having moderate to severe diarrhea that comes and goes for days. Over-the-counter anti-diarrheal medicine like loperamide (Imodium) hasn’t helped much, and they’re thinking about stopping the drug because of the symptoms. The post is an individual report — not a formal study — so it’s one person’s experience, not proof of what will happen to others. Semaglutide is the active ingredient in drugs you’ve probably heard of, like Ozempic and Wegovy. It’s a lab-made version of a natural gut hormone that tells your brain you’re full, slows how fast your stomach empties, and helps lower blood sugar. Doctors use it to treat type 2 diabetes and, at higher doses, to help people lose weight. It’s given as a once-weekly injection and people are usually started on a low dose that’s slowly increased every few weeks to reduce side effects. What this report shows is a real-world side effect: ongoing diarrhea that started after the dose was increased. Clinical trials and drug labels list gastrointestinal issues — nausea, vomiting, constipation, and diarrhea — as common side effects. Most trial data come from groups of people and show that these symptoms are usually mild to moderate and often lessen over time. But this post is an anecdote: one person’s diarrhea seems more severe and resistant to OTC treatment. That means it’s important to take it seriously, but you can’t generalize from it to everyone on semaglutide. Why this matters: if you or someone you know is trying semaglutide, this is a reminder that gut side effects can be significant for some people. Diarrhea can be more than annoying — it can make you feel weak, dehydrated, and interfere with work or daily life. It can also affect whether someone wants to continue the medication even if it’s helping with weight or blood sugar. Patients starting or increasing semaglutide should know to watch for persistent GI symptoms and talk to their clinician rather than suffering in silence. Important caveats and risks: this is a single-person report, so it doesn’t tell us how common severe diarrhea is. Diarrhea from any cause can lead to dehydration and electrolyte imbalance, so persistent or severe symptoms need medical evaluation. Stopping semaglutide abruptly can be considered, but you should discuss it with your prescriber to weigh benefits and alternatives and to rule out other causes like infections, food issues, or interactions with other medicines. If diarrhea is severe, has blood, or comes with fever, seek immediate care. Semaglutide is approved for certain uses; using it without medical supervision or ignoring serious side effects isn’t safe. Bottom line: persistent diarrhea after increasing semaglutide is a known possible side effect for some people — don’t ignore it, and contact your healthcare provider to decide whether to adjust the dose, try treatments, or stop the drug.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE